FEMSelect

Indonesia
Batusopang, East Kalimantan, Indonesia, 7177871

Company profile

FEMSelect company profile

FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

Business identity

Contact email
[email protected]
Phone number
1 215-940-8178
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2012-01-01, Year

Headquarters

Postal code
7177871
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
7
Total equity funding
$12M
Last funding
Series B / 2025-05-13
Last equity funding
Series B
Investors
14
Lead investors
3
Founders
2
Articles
11

Founders and investors

Founders

Boaz HarariProf. Menahem Neuman

Lead investors

Mid Atlantic Bio AngelsNew Age VenturesTriventures

Investors

Keiretsu CapitalMEDA AngelsNew Age VenturesNew York AngelsTriventures